Paloma Partners Management CO Trevena Inc Transaction History

Paloma Partners Management CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$1.39 - $2.25 $396,426 - $641,697	-285,199 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.44 - $2.24 $410,686 - $638,845	285,199 New	285,199 $411,000
Q1 2018 May 15, 2018	SELL	$1.51 - $2.06 $68,856 - $93,936	-45,600 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.4 - $2.6 $63,839 - $118,560	45,600	45,600 $73,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.